Nanogenecs is building a device that helps you measure your blood chemistry at home painlessly and makes it an essential part of how we will engage with our physical wellbeing or chronic conditions. We are focused on solving meaningful unmet needs to enable a future of personalized and pro-active preventive health. In an increasingly quantified AI driven world, our health still relies on an annual physical as the most proactive dialogue with our physician. It's time to engage with our bodies to uncover how our lifestyle choices and work outs impact our health. Wearables provide us a way to quantify our actions by tracking activity, but to understand their impact on our health we must look deeper to the gold standard of our health information, our blood. Our proprietary nano technology is patent pending and brings a new class of lab quality molecular sensing directly to the palm of your hand!
| Website | http://www.nanogenecs.com |
| Revenue | $3 million |
| Employees | 3 (0 on RocketReach) |
| Founded | 2016 |
| Industry | Environmental Services, Molecular Diagnostics, Health, Wellness and Fitness, Consumer Health, Home Diagnostics , Point Of Care |
| Keywords | At Home Diagnostics, Point Of Care Diagnostics, Chronic Disease Management, Personal Diagnostics, Medical Device Development, Digital Health Technology, Remote Patient Monitoring, Wellness Technology, Blood Glucose Monitoring |
| Competitors | Roche, Thermo Fisher Scientific, Abbott, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Genexine, Inc., Moleculera Labs +44 more (view full list) |
Looking for a particular Nanogenecs Diagnostics employee's phone or email?
The Nanogenecs Diagnostics annual revenue was $3 million in 2026.
Nanogenecs Diagnostics is based in Cambridge, Cambridgeshire.